Gerd Maass
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Oncology top 10%
- CAR-T cell therapy research
Papers in
-
- Immunotherapy and Immune Responses 9
- T-cell and B-cell Immunology 2
- Immune Cell Function and Interaction 2
-
- RNA Interference and Gene Delivery 3
- Viral Infectious Diseases and Gene Expression in Insects 2
- vaccines and immunoinformatics approaches 2
- Co-authors
- Max L. Birnstiel (5 shared papers)Wolfgang Schmidt (5 shared papers)M Berger (5 shared papers)Tamás Schweighoffer (3 shared papers)F. Schilcher (2 shared papers)Petra Heinmöller (1 shared paper)M. Pedrocchi (1 shared paper)Kurt Beyser (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Journal of Virology (1 paper)Journal of Molecular Medicine (1 paper)The Journal of Immunology (1 paper)Gene Therapy (1 paper)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Gerd Maass
12 papers receiving 651 citations
Peers
Comparison fields: 5 of 47
- Immunology 260
- Oncology 260
- Agronomy and Crop Science 76
- Genetics 201
- Biotechnology 46
Countries citing papers authored by Gerd Maass
This map shows the geographic impact of Gerd Maass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerd Maass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerd Maass more than expected).
Fields of papers citing papers by Gerd Maass
This network shows the impact of papers produced by Gerd Maass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerd Maass. The network helps show where Gerd Maass may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerd Maass, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | HER2 status in non-small cell lung cancer: results from patient screening for enrollment to a phase II study of herceptin. | 2003 | 151 |
| 2 | 1995 | 111 | |
| 3 | 1990 | 91 | |
| 4 | 1995 | 84 | |
| 5 | 1994 | 78 | |
| 6 | 1995 | 77 | |
| 7 | 1997 | 40 | |
| 8 | 1996 | 32 | |
| 9 | 1997 | 11 | |
| 10 | 1995 | 4 | |
| 11 | 1997 | 3 | |
| 12 | Genetic modification of cells by receptor-mediated adenovirus-augmented gene delivery: a new approach for immunotherapy of cancer. | 1994 | 3 |
About Gerd Maass
Gerd Maass is a scholar working on Immunology, Molecular Biology, Oncology, Genetics and Cardiology and Cardiovascular Medicine, having authored 12 papers that have together received 685 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (5 papers), Virus-based gene therapy research (5 papers), RNA Interference and Gene Delivery (3 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), vaccines and immunoinformatics approaches (2 papers), T-cell and B-cell Immunology (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Immunology (260 citations), Oncology (260 citations), Agronomy and Crop Science (76 citations), Genetics (201 citations) and Biotechnology (46 citations). Gerd Maass has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Max L. Birnstiel, Wolfgang Schmidt, M Berger, Tamás Schweighoffer, F. Schilcher, Petra Heinmöller, M. Pedrocchi, Kurt Beyser, Josef Rüschoff and Ernst Wagner. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Virology, Journal of Molecular Medicine, The Journal of Immunology and Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.